Search

New Hemorrhagic Cystitis Clinical Trial

Updated: Nov 9

A clinical trial for hemorrhagic cystitis testing a new experimental drug, LP-10 (intravesical tacrolimus) is open for enrollment for qualifying patients at sites in the Pittsburgh, PA and Detroit, MI areas. The trial sponsor is Lipella Pharmaceuticals.

The title of the trial is: A Multicenter, Dose-Ranging, Placebo-Controlled Trial Evaluating the Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis.


To learn more, including inclusion/exclusion criteria and contact information, see the ClinicalTrials.gov entry in the link (https://clinicaltrials.gov/ct2/show/NCT03129126). ClinicalTrials.gov Identifier: NCT03129126.

​Disclaimer: This post is not a recommendation to join the trial and was made for awareness only. Please weigh all trial details and consult with a healthcare professional before enrolling in any potential clinical trial.

Recent Posts

See All

Cancer Support Links

A few weeks ago, a very thoughtful member of the community sent us a list of resources to help people coping with the physical and emotional toll cancer takers. I've copied them below. Thank you April

Disclaimer: The material provided in this website is for general informational purposes only. Please do not consider this content medical advice or instruction.  Any information that you may consider on this website should be discussed with a healthcare professional. 


© 2020 by The Bladder Health Foundation

Contact Address: 
Raditation Cystitis Foundation
c/o Bladder Health Foundation
radiationcystitisfoundation@gmail.com